Ichiko Kinjyo
- Immunology top 1%
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Epidemiology top 10%
- Co-authors
- Akihiko YoshimuraWolfgang WeningerToshikatsu HanadaHiroyuki MoriSteven L. ReinerTakashi KobayashiMasato KuboMasanobu Ohishi
- Topics
- Cytokine Signaling Pathways and Interactions (13 papers)interferon and immune responses (8 papers)Immune Cell Function and Interaction (6 papers)
- Cited by
- ImmunologyOncologyPharmacology
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Ichiko Kinjyo
30 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Immunology 2.3k
- Oncology 1.5k
- Molecular Biology 922
- Cancer Research 360
- Epidemiology 300
Countries citing papers authored by Ichiko Kinjyo
This map shows the geographic impact of Ichiko Kinjyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiko Kinjyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiko Kinjyo more than expected).
Fields of papers citing papers by Ichiko Kinjyo
This network shows the impact of papers produced by Ichiko Kinjyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiko Kinjyo. The network helps show where Ichiko Kinjyo may publish in the future.
Co-authorship network of co-authors of Ichiko Kinjyo
This figure shows the co-authorship network connecting the top 25 collaborators of Ichiko Kinjyo. A scholar is included among the top collaborators of Ichiko Kinjyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiko Kinjyo. Ichiko Kinjyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 117 | |
| 3 | 141 | |
| 4 | 55 | |
| 5 | 119 | |
| 6 | 2 | |
| 7 | 70 | |
| 8 | 29 | |
| 9 | Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responsesbreakdown → | 643 |
| 10 | 8 | |
| 11 | 196 | |
| 12 | 207 | |
| 13 | 217 | |
| 14 | 49 | |
| 15 | 64 | |
| 16 | 98 | |
| 17 | 229 | |
| 18 | SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activationbreakdown → | 540 |
| 19 | 65 | |
| 20 | 331 |
About Ichiko Kinjyo
Ichiko Kinjyo is a scholar working on Immunology, Oncology and Pharmacology, having authored 30 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (13 papers), interferon and immune responses (8 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (1.5k citations) and Pharmacology (287 citations). Ichiko Kinjyo has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Akihiko Yoshimura, Wolfgang Weninger, Toshikatsu Hanada, Hiroyuki Mori, Steven L. Reiner, Takashi Kobayashi, Masato Kubo, Masanobu Ohishi, Daisuke Aki and Hiroki Yoshida. Their work appears in journals such as Science, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.